Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05000515 · ClinicalTrials.gov registry record · NA

Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise

A NA study of Hypertension and Aging, sponsored by University of Colorado, Boulder.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05000515 is a NA study of Hypertension and Aging that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 90 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05000515, a NA study of Hypertension and Aging, is actively recruiting participants, sponsored by University of Colorado, Boulder.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

High blood pressure (BP) is the major modifiable risk factor for cardiovascular diseases (CVD) and related health conditions, particularly among postmenopausal (PM) women. In adults age ≥50 years this risk is primarily driven by above-normal systolic BP (SBP ≥120 mmHg), as diastolic BP plateaus, then decreases in older adulthood. Although SBP is lower in premenopausal women vs. age-matched men, SBP reaches, then surpasses men after age 60. As such, \>75% of PM women in the U.S. have above-normal SBP, which, in turn, is responsible for a 2-fold increase in risk of hypertension and corresponding increases in risk of CVD, chronic kidney disease and many other disorders. A key process linking high SBP to CVD and related conditions is vascular endothelial dysfunction, mediated by excessive reactive oxygen species (ROS)-induced oxidative stress and reductions in nitric oxide (NO) bioavailability. As the number of PM women is rapidly growing, further increases in SBP-related CV disorders are projected without effective intervention. * Aerobic exercise (AE) is a first-line, standard-of-care therapy for lowering BP. In PM women with baseline SBP ≥120 mmHg, AE reduces casual (resting) SBP by \~3 mmHg (back to baseline ≤4 weeks post-training), whereas 24-hour SBP is typically unchanged. However, only 25-30% of PM women meet guidelines for 150 min/week of moderate-intensity AE, citing the extensive time requirement, facility access and travel disruptions as major barriers. Another, far less recognized, limitation is that AE training consistently improves endothelial function in midlife/older men, but not in estrogen-deficient PM (PMe-) women, i.e., in \>95% of the 60+million PM women in the U.S. Thus, establishing new lifestyle therapies that induce and sustain reductions in SBP and increases in endothelial function in PMe- women with above-normal SBP is an important public health goal. * High-resistance inspiratory muscle strength training (IMST) is a time-efficient (5 minute

Interventions

  • OTHER High-resistance inspiratory muscle strength training
  • OTHER Aerobic exercise

Study Locations (1)

Colorado

  • Integrative Physiology of Aging Laboratory - Boulder

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2022-04-19
Est. Completion 2027-02-28
Phase NA

Sponsor

University of Colorado, Boulder

69 total trials

What the Registry Record Tells You About NCT05000515

The ClinicalTrials.gov registry entry for NCT05000515 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which High-resistance inspiratory muscle strength training is the first listed.

NCT05000515 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05000515 about?

NCT05000515 is a clinical study titled "Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise". High blood pressure (BP) is the major modifiable risk factor for cardiovascular diseases (CVD) and related health conditions, particularly among postmenopausal (PM) women. In adults age ≥50 years this risk is primarily driven by above-normal systolic BP (SBP ≥120 mmHg), as diastolic BP plateaus, the...

What is the current status of trial NCT05000515?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-04-19. Estimated completion is 2027-02-28.

What conditions does trial NCT05000515 study?

This clinical trial studies the following conditions: Hypertension, Aging, Blood Pressure, Endothelial Dysfunction.

What interventions are being tested in trial NCT05000515?

The interventions under investigation include: High-resistance inspiratory muscle strength training (OTHER), Aerobic exercise (OTHER).

Who is sponsoring clinical trial NCT05000515?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05000515 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.